These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 4330275

  • 1. Treatment of malignant brain tumors with nitrosoureas.
    Hansen HH, Muggia FM.
    Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275
    [No Abstract] [Full Text] [Related]

  • 2. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB, Boldrey EB, Enot KJ.
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract] [Full Text] [Related]

  • 3. Lack of correlation between clinical and angiographic findings in patients with brain tumors under BCNU chemotherapy.
    Koo AH, Fewer D, Wilson CB, Newton TH.
    J Neurosurg; 1972 Jul; 37(1):9-14. PubMed ID: 4338690
    [No Abstract] [Full Text] [Related]

  • 4. Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.
    Rosenblum ML, Reynolds AF, Smith KA, Rumack BH, Walker MD.
    J Neurosurg; 1973 Sep; 39(3):306-14. PubMed ID: 4354763
    [No Abstract] [Full Text] [Related]

  • 5. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK, Newman JW.
    Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
    [No Abstract] [Full Text] [Related]

  • 6. Structure-activity relationships: nitrosoureas.
    Johnston TP.
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR.
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract] [Full Text] [Related]

  • 8. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA, DeVita VT, Adamson RH, Oliverio VT.
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract] [Full Text] [Related]

  • 9. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD, Hurwitz BS.
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract] [Full Text] [Related]

  • 10. Further studies on chemotherapy of experimental brain tumors.
    Shapiro WR.
    Neurology; 1970 Apr; 20(4):390-1. PubMed ID: 5535017
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of mycosis fungoides with topical nitrosourea compounds.
    Zackheim HS.
    Arch Dermatol; 1972 Aug; 106(2):177-82. PubMed ID: 5048217
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC, DeVita VT, Serpick AA, Canellos GP.
    N Engl J Med; 1971 Aug 26; 285(9):475-9. PubMed ID: 5558887
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Ahmann DL, Hahn RG, Bisel HF.
    Cancer Chemother Rep; 1972 Feb 26; 56(1):93-4. PubMed ID: 5030810
    [No Abstract] [Full Text] [Related]

  • 16. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma.
    Thomson JM, Maruyama Y, Schwartz S, Hahn E.
    Radiology; 1971 Oct 26; 101(1):187-94. PubMed ID: 4329540
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL.
    Vopr Onkol; 2007 Oct 26; 53(6):724-9. PubMed ID: 18416147
    [No Abstract] [Full Text] [Related]

  • 18. [Induction of stomach cancer and neurogenic malignoma by oral administration of methyl-nitrosobiuret (MNB) in rats].
    Druckrey H, Landschïtz C, Preussmann R, Ivankovic S.
    Z Krebsforsch; 1971 Feb 26; 75(3):229-39. PubMed ID: 4256419
    [No Abstract] [Full Text] [Related]

  • 19. [Increase in toxicity of alkylate nitrosourea compounds by reaction with heavy metals].
    Zeller WJ, Ivankovic S.
    Naturwissenschaften; 1972 Feb 26; 59(2):82. PubMed ID: 5015757
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical trial of MCNU for malignant brain tumors].
    Harada K, Okamoto H, Fujioka Y, Uozumi T, Kiya K, Kitaoka T, Goishi A, Sasaki U, Shima T, Inagawa T.
    Gan To Kagaku Ryoho; 1985 Jul 26; 12(7):1423-31. PubMed ID: 2990350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.